TrialThe Journal of infectious diseases2022

Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study.

Chukiat Sirivichayakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.